Illumina Inc at Piper Jaffray Healthcare Conference Transcript
All right. Thanks. Good morning, everyone. Welcome to the 10:30 session. I'm Bill Quirk, the Tools and Diagnostics Analyst here at Piper Jaffray. And I have the pleasure of welcoming to the podium the Chief Financial Officer from Illumina, Sam Samad. Sam has some opening comments, and then we will get right into Q&A. Sam?
Yes. Thank you, Bill. So I would like to start with the safe harbor, and then we can go straight to Q&A, if that's okay.
So I've been asked to remind you that my comments today could include forward-looking statements. You should refer to our SEC filings for a discussion of the risks and uncertainties that could cause results to differ materially from our current expectations. It is our intent that all forward-looking statements regarding our financial results and commercial activity made during today's discussion will be protected under the Private Securities Litigation Reform
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

